LEIDEN, Netherlands--(BUSINESS WIRE)--to-BBB, a biopharmaceutical company pioneering treatments for devastating brain diseases, today announced significant additions to complete its new management team as well as changing its name from to-BBB technologies B.V. to BBB Therapeutics B.V. Dr. Ferdinand (Ferd) Massari and Dr. Pericles (Perry) Calias have joined BBB as Chief Medical Officer and as Chief Scientific Officer, respectively. Completing the management team are recently appointed Chief Executive Officer Dr. Anders Harfstrand, and Chief Financial Officer Leon Kruimer and Chief Business Officer Dr. Carlos de Sousa, both of whom joined the company in January of 2014.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
